{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-042785","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2022-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.940059+00:00","generated_at":"2026-06-26T09:20:06.671511+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CytoSorbents appoints Jiny Kim to Board of Directors as independent director","bullets":["Appointment effective April 1, 2022; term expires at June 7, 2022 annual meeting, where she is expected to stand for re-election.","Board expanded from five to six members; Kim brings medical device experience from Zimmer Biomet, LivaNova, and Johnson & Johnson.","Kim currently VP at Zimmer Biomet leading Smart Implants portfolio, including launch of Persona IQ® smart knee implant.","She will receive standard non-employee director compensation; committee assignments not yet determined.","Company's CEO and Chairman cite her experience as valuable for U.S. expansion and potential FDA approval of DrugSorb™-ATR."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-042785","json":"https://secwatch.observer/filing/0001104659-22-042785.json","markdown":"https://secwatch.observer/filing/0001104659-22-042785.md","text":"https://secwatch.observer/filing/0001104659-22-042785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/0001104659-22-042785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/tm2210684d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:20:06.671511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7993eeb291","claim":"Jiny Kim was appointed as Director at Cytosorbents Corp.","evidence_excerpt":"On April 1, 2022, the Board of Directors (the \"Board\") of CytoSorbents Corporation (the \"Company\") increased the size of the Board from five to six, and upon the recommendation of the Company’s Nominating and Corporate Governance Committee, appointed Ms. Jiny Kim to the Board to fill the resulting vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/0001104659-22-042785-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}